Shaman Botanicals
This article was originally published in The Tan Sheet
Executive Summary
Loren Israelsen named interim CEO at the new company. President of the consulting firm LDI Group, Israelsen will engage in early financing activities, negotiating partnering agreements and recruiting a full-time management team. Thomas Carlson, MD, senior director of ethnobiomedical field research at parent Shaman Pharmaceuticals, joins the interim team as acting VP of medical ethnobotany
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning